A 52-year-old male from Tamil Nadu presents with a 3-month history of unilateral cervical lymphadenopathy and epistaxis. Nasopharyngoscopy reveals a mass in the nasopharynx. Biopsy confirms undifferentiated carcinoma (WHO type III). CT staging shows T3N2M0 disease. What is the drug of choice for induction chemotherapy in this patient?

See the options, answer & explanation

Sign in free to reveal the answer choices, the correct answer, the detailed explanation, and AI-powered insights for this question.